• A New Paradigm in
    Blood Viscosity Measurement

    The world’s first fully automated blood viscosity analyzer enables early diagnosis of cardiovascular disease.

    Certified by the Ministry of Health and Welfare, FDA-approved & U.S. patented

  • Detecting Hidden Risks
    at an Early Stage

    Blood viscosity testing enables proactive management of cardiovascular disease.

    Clinically validated worldwide, first technology to be commercialized

  • An Innovative
    Diagnostic Solution

    The world’s first scanning capillary method enables early detection of cardiovascular disease.

    Certified by the Ministry of Health and Welfare, FDA-approved & U.S. patented

  • A Diagnostic Solution
    Recognized Worldwide

    Biorheologics’ innovative device delivers accuracy and reliability.

    Proprietary technology with international patents, advancing global healthcare standards

Find Out
More

PRODUCT

Blood Viscosity Analyzers
Powered by Innovative Technology

Based on the scanning capillary method,
effective for early disease diagnosis and prognosis prediction.

CLINICAL

Clinical Value and Real-World Outcomes

  • 1st

    World’s First

    Fully Automated
    Blood Viscosity Analyzer

  • 100+

    Hospital Adoption

    Installed in major
    university hospitals and labs

  • 3

    Major Diseases

    Cardiovascular,
    Cerebrovascular,
    Peripheral Vascular

  • FDA

    Global Certification

    FDA-approved and
    U.S. patented

PARTNERSHIP

Research Highlights & News

SUPPORT

Need Help?

FAQ

Find answers to frequently asked
questions about our products.

Contact Us

If you have any questions, please leave us a message.
We will respond quickly and accurately.